UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 14,
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more VistaGen Therapeutics Charts.
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more VistaGen Therapeutics Charts.

Vistagen Therapeutics, Inc. News

Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
Thursday 25 April 2024 (6 days ago) • Business Wire
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Tuesday 9 April 2024 (3 weeks ago) • Business Wire
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Monday 1 April 2024 (1 month ago) • Business Wire
Vistagen to Present at Stifel 2024 Virtual CNS Days
Monday 11 March 2024 (2 months ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
Wednesday 28 February 2024 (2 months ago) • Business Wire
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

More Vistagen Therapeutics, Inc. News Articles